Prostate Cancer Treatment Manchester NH

Turning up the heat may provide a less invasive, more promising treatment for prostate cancer. Blasting the cancer with a treatment that uses high-intensity focused ultrasound (HIFU) to kill cancer cells and surrounding prostate tissue offers myriad benefits over conventional treatments. HIFU can be performed under a spinal block—versus general anesthesia—most often on an outpatient basis.

Charles George Leutzinger, MD
(603) 628-1800
1 Elliot Way
Manchester, NH
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Male
Education
Medical School: Univ Of Ct Sch Of Med, Farmington Ct 06032
Graduation Year: 1976

Data Provided by:
Brian Robert Knab
(603) 663-1800
1 Elliot Way
Manchester, NH
Specialty
Radiation Oncology

Data Provided by:
Karen Jane Hoffmeister
(603) 629-1827
100 Hitchcock Way
Manchester, NH
Specialty
Hematology / Oncology

Data Provided by:
Meredith J Sellec, MD
(603) 622-6484
200 Technology Dr
Hooksett, NH
Specialties
Oncology (Cancer)
Gender
Male
Education
Graduation Year: 2007

Data Provided by:
Danny Michael Sims, MD
(603) 622-6484
200 Technology Dr
Hooksett, NH
Specialties
Internal Medicine, Medical Oncology
Gender
Male
Education
Medical School: Emory Univ Sch Of Med, Atlanta Ga 30322
Graduation Year: 1985

Data Provided by:
Donald Raabe Weiss, MD
(603) 663-1800
1 Elliot Way
Manchester, NH
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Male
Languages
Other
Education
Medical School: Univ Of Co Sch Of Med, Denver Co 80262
Graduation Year: 1965
Hospital
Hospital: St Joseph Hospital And Trauma, Nashua, Nh; Elliot Hosp, Manchester, Nh; Concord Hosp, Concord, Nh; Wentworth-Douglass Hospital, Dover, Nh; Exeter Hosp, Exeter, Nh
Group Practice: Elliot Regional Cancer Ctr

Data Provided by:
Thomas Andrew Sheldon, MD
(603) 669-5300
1 Elliot Way
Manchester, NH
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Male
Education
Medical School: Tufts Univ Sch Of Med, Boston Ma 02111
Graduation Year: 1980
Hospital
Hospital: Elliot Hosp, Manchester, Nh
Group Practice: New Hampshire Medical Lab

Data Provided by:
Jack Terry Evjy, MD
(978) 685-7811
21 Bowman Parade Rd
Bedford, NH
Specialties
Oncology (Cancer), Hematology-Internal Medicine
Gender
Male
Education
Medical School: Boston Univ Sch Of Med, Boston Ma 02118
Graduation Year: 1961
Hospital
Hospital: Holy Family Hosp And Med Ctr, Methuen, Ma
Group Practice: Commonwealth Hematology-Onclgy

Data Provided by:
Meredith J Selleck
(603) 622-6484
200 Technology Dr
Hooksett, NH
Specialty
Hematology / Oncology

Data Provided by:
Danny M Sims
(603) 622-6484
200 Technology Dr
Hooksett, NH
Specialty
Hematology / Oncology

Data Provided by:
Data Provided by:

Heal Thyself—Prostate Cancer

Provided by: 

By Barbara Hey

Turning up the heat may provide a less invasive, more promising treatment for prostate cancer. Blasting the cancer with a treatment that uses high-intensity focused ultrasound (HIFU) to kill cancer cells and surrounding prostate tissue offers myriad benefits over conventional treatments according to John Warner, MD, the medical director of the Maple Leaf HIFU Company in Vancouver, British Columbia. Maple Leaf HIFU manufactures Ablatherm HIFU, the machine currently used for this procedure.

• HIFU can be performed under a spinal block—versus general anesthesia—most often on an outpatient basis, Warner explains, with no incision and no attendant loss of blood. Studies confirm HIFU’s effectiveness in combating the disease, and because it’s noninvasive, the procedure is less likely to damage surrounding nerves and tissue. A study published in the Journal of Urology in 2003 found that five years after treatment, 87 percent of patients had stable prostate specific antigen (PSA) levels. High or rising levels suggest the presence of the disease.

• If treated early, before it spreads, prostate cancer has a nearly 100 percent five-year survival rate, according to the Prostate Cancer Foundation. Though the common methods of treatment (radiation and surgery) work effectively, they have a number of ser-ious risks associated with them. With radiation administered externally—called external beam radiotherapy—the beam can damage surrounding tissue, skin, and muscle en route to the prostate, and patients commonly require multiple treatments. Another option is brachytherapy in which radioactive pellets are inserted surgically into the prostate. The risk of this type of radiation is that the effects can extend beyond the prostate itself. A third option, surgery, requires general anesthesia and hospitalization, which both carry risks. A much more aggressive tactic, surgery involves not just removal of the prostate, but also portions of the seminal ducts and part of the bladder. Common aftereffects of all these treatments include impotence and incontinence.

• For the HIFU treatment, a probe is inserted in the rectum to guide the ultrasound to the prostate using computer imaging. The focused beam of sound reaches a heat of 85 degrees Celsius, killing the cells of the prostate (dead tissue is excreted later in the urine) while skirting the surrounding nerves and muscles. And according to Warner, 90 percent of the patients require just one treatment, which may last 90 minutes to three hours.

• Currently only the Don Mills Surgical Unit in Toronto offers Ablatherm HIFU treatment, but that may change in the near future. FDA-monitored studies comparing HIFU with cryotherapy (freezing the tissue, commonly used as a second-line of treatment) on patients with a recurrence of the disease will begin in 2006, setting the stage for the treatment to one day be available in the US.

Copyright 1999-2009 Natural Solutions: Vibrant Health, Balanced Living/Alternative Medicine/InnoVisi...